These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11027099)

  • 21. Fracture risk associated with parkinsonism and anti-Parkinson drugs.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2007 Sep; 81(3):153-61. PubMed ID: 17705047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular parkinsonism: a clinical review.
    Benamer HT; Grosset DG
    Eur Neurol; 2009; 61(1):11-5. PubMed ID: 18948694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of severe parkinsonism associated with short-term treatment with milnacipran.
    Muraoka T; Oku E; Sugataka K; Yamada S
    Clin Neuropharmacol; 2008; 31(5):299-300. PubMed ID: 18836350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quetiapine use in a patient with chronic schizophrenia and severe parkinsonism.
    Stoner SC; Lea JW; Wolf AL; Berges AA
    Pharmacotherapy; 2005 Nov; 25(11):1651-5. PubMed ID: 16232027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical response to apomorphine in a case of atypical parkinsonism.
    Cicarelli G; Pellecchia MT; De Michele G; Pizzolato G; Barone P
    Mov Disord; 2002 May; 17(3):604-6. PubMed ID: 12112216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys.
    Hsu A; Togasaki DM; Bezard E; Sokoloff P; Langston JW; Di Monte DA; Quik M
    J Pharmacol Exp Ther; 2004 Nov; 311(2):770-7. PubMed ID: 15226382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice.
    Xu R; Hranilovic D; Fetsko LA; Bucan M; Wang Y
    Mol Psychiatry; 2002; 7(10):1075-82. PubMed ID: 12476322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily.
    Morgante L; Nicoletti A; Epifanio A; Contrafatto D; Savica R; Lanzafame S; Musolino R; La Spina P; Bonuccelli U; Marconi R; D'Amelio M; Savettieri G; Zappia M
    Parkinsonism Relat Disord; 2008 Nov; 14(7):572-5. PubMed ID: 18325817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Familial parkinsonism with the abnormalities in putamen on MRI].
    Kuru S; Kato T; Sakai M; Konagaya M; Sobue G; Matsuoka Y
    Rinsho Shinkeigaku; 2000 Jul; 40(7):741-5. PubMed ID: 11186916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimetazidine: a new cause for drug-induced parkinsonism?
    Sommet A; Azaïs-Vuillemin C; Bagheri H; Rascol O; Montastruc JL
    Mov Disord; 2005 Aug; 20(8):1080-1. PubMed ID: 16007626
    [No Abstract]   [Full Text] [Related]  

  • 33. Diabetes mellitus and drug-induced Parkinsonism: a case-control study.
    Ma HI; Kim JH; Chu MK; Oh MS; Yu KH; Kim J; Hahm W; Kim YJ; Lee BC
    J Neurol Sci; 2009 Sep; 284(1-2):140-3. PubMed ID: 19467671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The parkinsonian phenotype of spinocerebellar ataxia type 2.
    Lu CS; Wu Chou YH; Kuo PC; Chang HC; Weng YH
    Arch Neurol; 2004 Jan; 61(1):35-8. PubMed ID: 14732617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinsonism due to lamotrigine.
    Santens P; Claeys I; Vonck K; Boon P
    Mov Disord; 2006 Dec; 21(12):2269-70. PubMed ID: 17013910
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drugs induced Parkinsonism: the case of a 77 year old woman].
    Arzur J; De la Gastine B; Bessodes A; Coquerel A
    Rev Med Interne; 2006 May; 27(5):422-4. PubMed ID: 16360242
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug-induced Parkinsonism].
    López Pardo P
    Rev Esp Geriatr Gerontol; 2019; 54(3):181-183. PubMed ID: 30770215
    [No Abstract]   [Full Text] [Related]  

  • 38. First Report of Parkinsonism Associated With Indoximod, an Immune-Modulating Agent.
    Floyd M; El Osta B; Tang SC
    J Glob Oncol; 2018 Sep; 4():1-2. PubMed ID: 30241153
    [No Abstract]   [Full Text] [Related]  

  • 39. Patient with parkinsonism and a history of methanol toxicity.
    Enriquez-Marulanda A; Ospina-Delgado D; Arias-Mora F; Amaya-González P; Orozco JL
    Neurologia (Engl Ed); 2019 Oct; 34(8):555-556. PubMed ID: 28108118
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemical structure of substances effective in treatment of Parkinsonism.
    GAIR DS; DUCEY J
    Arch Intern Med (Chic); 1950 Feb; 85(2):284-98. PubMed ID: 15405895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.